{"id":71273,"date":"2025-09-18T09:59:36","date_gmt":"2025-09-18T09:59:36","guid":{"rendered":"https:\/\/kanboapp.com\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/"},"modified":"2025-09-18T09:59:36","modified_gmt":"2025-09-18T09:59:36","slug":"transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists","status":"publish","type":"page","link":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/","title":{"rendered":"Transforming Pharmaceutical Risk Management: Enhancing Visibility to Navigate Regulatory Safety and Market Challenges for Senior Data Scientists"},"content":{"rendered":"<style> @media(min-width:1728px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{    flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;}  .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy { margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media(min-width: 1440px) and (max-width:1727px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 1024px) and (max-width:1439px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2{ display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 782px) and (max-width:1023px) { .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;}  .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:60%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:32px!important; } .pasek-prawy {margin-right:32px!important; } } @media (max-width:781px) {  .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 16px!important; margin-right: 16px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:100%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:none!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:16px!important; } .pasek-prawy {margin-right:16px!important; } } .prawy-link a:hover { color:#145A92!important} .banner { margin-top:80px; margin-bottom:80px; } .jazda-nowsza { position:sticky!important; top: 120px; overflow: auto; max-height: 85vh; }  .fobrazek { margin-bottom: -40px!important; } .sekcja5-przycisk a:hover { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; }  .sekcja5-przycisk a:focus { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; } .vlp-layout-blogs .vlp-block-0 {font-weight: 600!important; } .prawy-tytul-pulpit {font-size:19px!important;} .ct-container-narrow {max-width: 1200px!important;}  :nth-last-child(1 of .tekst-para) {margin-bottom: 0px!important;} <\/style><script> function lewemenu(zm) { var elements = document.getElementsByClassName(\"menu-lewe\"); var i,link1,link2; for (i = 0; i < elements.length; i++) {    link1 = elements[i].getElementsByTagName(\"a\");     link1[0].style.fontWeight = \"600\";     link1[0].style.backgroundColor= \"#FAFAFA\"; } link2 = elements[zm].getElementsByTagName(\"a\"); link2[0].style.fontWeight = \"600\"; link2[0].style.backgroundColor= \"#E9F4FE\"; } <\/script><div class=\"wp-block-getwid-section alignfull alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background has-background\" style=\"background-color:#fafafa\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><div class=\"wp-block-columns alignfull artykul is-layout-flex wp-container-core-columns-is-layout-f96e3eba wp-block-columns-is-layout-flex\" style=\"margin-top:0px;margin-bottom:0px\"><div class=\"wp-block-column pasek-lewy spis jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><p class=\"menu-lewe wp-elements-811528bea7238c1b1da5b6b25d146465 wp-block-paragraph\" onclick=\"lewemenu(0)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section1\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section1\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Why change?<\/a><\/p><p class=\"menu-lewe wp-elements-da09cf86d8dd9ec653cb1203770c42ff wp-block-paragraph\" onclick=\"lewemenu(1)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section2\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section2\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Background \/ Definition<\/a><\/p><p class=\"menu-lewe wp-elements-d504b85f019abb40c4028a1ccae4c759 wp-block-paragraph\" onclick=\"lewemenu(2)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section3\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section3\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Case-Style Mini-Examples<\/a><\/p><p class=\"menu-lewe wp-elements-a496c082044612f16aac1e68867d4ffe wp-block-paragraph\" onclick=\"lewemenu(3)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section4\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section4\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will change?<\/a><\/p><p class=\"menu-lewe wp-elements-c0bbc227d4ac59c00ba003f4e376b78c wp-block-paragraph\" onclick=\"lewemenu(4)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section5\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section5\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will not change?<\/a><\/p><p class=\"menu-lewe wp-elements-b45f60dbc2757dd5dab6fcb1a2dc8629 wp-block-paragraph\" onclick=\"lewemenu(5)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section6\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section6\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Key management questions (Q\/A)<\/a><\/p><p class=\"menu-lewe wp-elements-5870b11f8cb362aa0c7d19742d17bb88 wp-block-paragraph\" onclick=\"lewemenu(6)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section7\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section7\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Atomic Facts<\/a><\/p><p class=\"menu-lewe wp-elements-7de46b443fbf2677d457f733701c4f6e wp-block-paragraph\" onclick=\"lewemenu(7)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section8\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section8\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Mini-FAQ<\/a><\/p><p class=\"menu-lewe wp-elements-00642cd372f5379e4bb473fec183aabb wp-block-paragraph\" onclick=\"lewemenu(8)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section9\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section9\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Data Table<\/a><\/p><p class=\"menu-lewe wp-elements-1cef00c9f9a9be49661bde7e0acf4a08 wp-block-paragraph\" onclick=\"lewemenu(9)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section10\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section10\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Answer Capsule<\/a><\/p><p class=\"menu-lewe wp-elements-a64c0666586f2703a12b4b1ba4766f86 wp-block-paragraph\" onclick=\"lewemenu(10)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section11\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#section11\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/a><\/p><\/div><\/div><\/div><div class=\"wp-block-column kolumna-tekst is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-getwid-section alignfull sekcja-tekst alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><h1 class=\"wp-block-heading tytulek\" style=\"margin-bottom:40px;font-style:normal;font-weight:700;letter-spacing:-0.34px;line-height:1.2\">Transforming Pharmaceutical Risk Management: Enhancing Visibility to Navigate Regulatory Safety and Market Challenges for Senior Data Scientists<\/h1><h2 class=\"wp-block-heading naglowek-duzy\" id=\"section1\">Why change?<\/h2><p class=\"tekst-para wp-block-paragraph\">The pharmaceutical industry operates in an environment characterized by high costs, stringent regulations, and intense scrutiny, making risk visibility a critical factor. Here are some key pressures and considerations surrounding risk visibility in this sector:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance: Pharmaceutical companies are subject to rigorous regulations from agencies like the FDA, EMA, and others. Non-compliance can result in substantial fines, product recalls, or even the suspension of operations. Therefore, maintaining clear visibility over risk-related processes ensures adherence to these stringent requirements.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Product Safety: Ensuring the safety of drugs through systematic risk management is imperative. Lack of visibility into potential risks can lead to adverse effects being unnoticed until it's too late, resulting in harm to patients and subsequent legal and reputational repercussions for the company.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Research & Development (R&D) Costs: Developing a new drug can take years and billions of dollars. Risks such as unsuccessful trials or unforeseen side effects can derail the entire process, leading to sunk costs. Visibility into these risks helps in making more informed, timely decisions to mitigate losses.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Supply Chain Complexity: Pharmaceutical supply chains are extensive and global, involving numerous stakeholders. Risks such as delivery delays, contamination during transport, or geopolitical disruptions can have significant impacts. Having visibility into these risks allows for better contingency planning and resource allocation.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Market Pressures: The pharmaceutical market is highly competitive, with constant pressure to innovate and deliver new products. Risk visibility can enhance decision-making processes by allowing companies to prioritize initiatives with the highest potential return on investment and the lowest risk.<\/p><p class=\"tekst-para wp-block-paragraph\">Quantifying the Risk of Inaction: <\/p><p class=\"tekst-para wp-block-paragraph\">The risk of inaction, or insufficient risk management, can have significant financial and operational impacts:<\/p><p class=\"tekst-para wp-block-paragraph\">- Financial Losses: Companies risk losing millions in non-compliance fines, recall costs, and lost sales revenue from sidelined products. For instance, a major recall alone can cost a company upwards of $100 million.<\/p><p class=\"tekst-para wp-block-paragraph\">- Product Delays: Delayed approval and time-to-market for new drugs can forfeit billions in potential revenue and allow competitors to capture market share.<\/p><p class=\"tekst-para wp-block-paragraph\">- Reputational Damage: A single adverse incident due to ignored risks can erode public trust and market value, which can take years to rebuild.<\/p><p class=\"tekst-para wp-block-paragraph\">- Operational Disruptions: Unforeseen supply chain interruptions can halt production lines, leading to costly downtime and unfulfilled contracts.<\/p><p class=\"tekst-para wp-block-paragraph\">While specific software solutions like KanBo can aid in visualizing and managing risks by providing a holistic view and fostering collaboration across teams, it's crucial for pharmaceutical companies to adopt a risk management mindset that integrates visibility into every aspect of the business, regardless of the tools used. This approach ensures that decisions are data-driven and strategically aligned with both corporate goals and compliance standards.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section2\">Background \/ Definition<\/h3><p class=\"tekst-para wp-block-paragraph\">Risk Visibility for a Senior Data Scientist in Pharmaceutical<\/p><p class=\"tekst-para wp-block-paragraph\">Defining Key Terms:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Risk Visibility: This refers to the capability of identifying, assessing, and managing potential risks that could impact a project or task. For a Senior Data Scientist in the pharmaceutical industry, this could include risks associated with data inaccuracies, model failures, regulatory compliance, and project timelines.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Card Blockers: These are specific issues or obstacles that halt the progress of a task. Understanding the type (local, global, or on-demand) helps in diagnosing whether the problem is internal to a team, affects the entire project, or can be resolved upon request. For a data scientist, this can mean blockers relating to data access or computational resources.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Date Conflict: Situations where timelines overlap or clash, leading to scheduling issues. In pharmaceutical data analytics, this could mean overlapping data analysis deadlines that could impact the timing of research outputs or drug approval processes.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Card Relation: These are dependencies between tasks that determine the workflow. For example, the completion of a data cleaning task (parent) might be necessary before analysis (child) can begin.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Notification: Alerts that keep team members informed of status changes, potential issues, or task completions. They ensure that relevant stakeholders in a pharmaceutical project are promptly updated about developments, helping to mitigate communication delays which could pose risks to project timelines.<\/p><p class=\"tekst-para wp-block-paragraph\">How KanBo Reframes Risk Visibility:<\/p><p class=\"tekst-para wp-block-paragraph\">Visible Blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo allows for the explicit creation and visualization of card blockers. By categorizing and displaying these blockers (local, global, on-demand), a data scientist can quickly see which issues need immediate attention and which might be resolved externally or at a later stage. This visibility helps prioritize resource allocation and effort.<\/p><p class=\"tekst-para wp-block-paragraph\">Mapped Dependencies:<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo\u2019s card relations allow for a clear mapping of dependencies. For a pharmaceutical data scientist, breaking down complex projects into smaller, dependent tasks can help streamline workflows. It clarifies the order of operations and ensures that no part of the project proceeds out of sequence, thus minimizing errors that could arise from premature task execution.<\/p><p class=\"tekst-para wp-block-paragraph\">Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo uses notifications to keep stakeholders continually informed. For a senior data scientist, receiving timely updates about changes in task statuses or potential issues means they can rapidly adjust plans or reallocate resources. This function turns potential risks into manageable elements by ensuring no information crucial for risk mitigation is missed.<\/p><p class=\"tekst-para wp-block-paragraph\">In conclusion, KanBo\u2019s framework of visible blockers, mapped dependencies, and proactive notifications transforms traditional risk management into an integrated, dynamic process where data scientists in the pharmaceutical industry can effectively manage and mitigate risks in their projects.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section3\">Case-Style Mini-Examples<\/h3><p class=\"tekst-para wp-block-paragraph\">Practical Case Example: Risk Visibility Challenges for a Senior Data Scientist in Pharmaceuticals<\/p><p class=\"tekst-para wp-block-paragraph\">Context:<\/p><p class=\"tekst-para wp-block-paragraph\">Dr. Alex Johnson, a Senior Data Scientist at PharmaTech Inc., is involved in a high-stakes clinical trial analysis, which is part of a broader initiative for developing a new cancer drug. Timely and accurate data analysis is crucial for regulatory compliance and ensuring successful outcomes.<\/p><p class=\"tekst-para wp-block-paragraph\">Challenge:<\/p><p class=\"tekst-para wp-block-paragraph\">Dr. Johnson's team traditionally used spreadsheets and email communication to track analysis progress and address issues, which led to several challenges:<\/p><p class=\"tekst-para wp-block-paragraph\">- Delays in Identifying Risks: Issues like data discrepancies weren't visible until they significantly affected the timeline, halting progress.<\/p><p class=\"tekst-para wp-block-paragraph\">- Inefficiency in Communication: Email threads around data issues were lengthy, making it hard to track resolutions or decisions.<\/p><p class=\"tekst-para wp-block-paragraph\">- Lack of Visibility Due to Manual Processes: Manually tracking task dependencies led to critical pathway bottlenecks being overlooked, exacerbating risks such as non-compliance or delays impacting time-to-market.<\/p><p class=\"tekst-para wp-block-paragraph\">Transition to KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo's Impact:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Visible Blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Dr. Johnson often discovered data access issues too late, causing project disruptions.<\/p><p class=\"tekst-para wp-block-paragraph\">   - With KanBo: Dr. Johnson uses the Card Blocker feature to identify blockers as local (team-specific data access issues) or global (company-wide resource bottlenecks). This distinction enables targeted issues resolution, prioritizing effectively for minimal delay.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Mapped Dependencies:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Dependencies like waiting for data cleansing before analysis were tracked manually, leading to missteps.<\/p><p class=\"tekst-para wp-block-paragraph\">   - With KanBo: KanBo's Card Relation feature clarifies task dependencies. Dr. Johnson now designs workflows where data cleansing tasks (parent cards) must be completed before analysis tasks (child cards) can begin, ensuring work proceeds in the right sequence.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Important updates on data quality and adjustments were missed due to overlooked emails.<\/p><p class=\"tekst-para wp-block-paragraph\">   - With KanBo: Notifications now keep Dr. Johnson informed of all changes around card status and comments. Instant alerts on data quality updates allow real-time task adjustments and decision-making, reducing risks of oversight.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Avoiding Date Conflicts:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Overlapping timelines of multiple datasets analyzed simultaneously led to resource conflicts.<\/p><p class=\"tekst-para wp-block-paragraph\">   - With KanBo: By using KanBo\u2019s Date Conflict feature, Dr. Johnson proactively identifies and resolves timing clashes. Aligning timelines accurately improved scheduling, thus avoiding resource bottlenecks.<\/p><p class=\"tekst-para wp-block-paragraph\">Outcome:<\/p><p class=\"tekst-para wp-block-paragraph\">- Enhanced Risk Mitigation: Dr. Johnson\u2019s data team can now proactively handle risks owing to the increased visibility and structured communication.<\/p><p class=\"tekst-para wp-block-paragraph\">- Efficiency and Compliance: Streamlined workflows and immediate access to critical updates lead to more efficient project execution, ensuring compliance with regulators like the FDA.<\/p><p class=\"tekst-para wp-block-paragraph\">- Organizational Success: Timely analysis and risk management shorten project timelines, safeguarding PharmaTech's investment in R&D and potentially accelerating time-to-market for the new drug.<\/p><p class=\"tekst-para wp-block-paragraph\">In conclusion, KanBo transforms risk visibility and management into an integrated part of daily operations for Dr. Johnson and PharmaTech Inc., leading to better risk assessment, enhanced communication, and strategic project delivery.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section4\">What will change?<\/h3><p class=\"tekst-para wp-block-paragraph\">Old School Tools vs. KanBo in Risk Visibility for Pharmaceutical Data Scientists<\/p><p class=\"tekst-para wp-block-paragraph\">The traditional tools and outdated methods often used in pharmaceutical data project management include simple spreadsheets, email communication, and basic project management software. These tools present challenges such as fragmented communication, poor visibility into ongoing tasks, and limited ability to manage dependencies effectively. Here's how KanBo addresses these issues:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Centralized Workspaces vs. Fragmented Communication:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Email threads and separate documents spread across multiple platforms result in a fragmented communication system.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: Utilizes centralized workspaces and spaces where relevant information, discussions, and documents are easily accessed, ensuring all team members and stakeholders have up-to-date information, enhancing risk visibility.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Dynamic Task Visualization vs. Static Spreadsheets:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Rely on static spreadsheets for tracking project progress, offering minimal interactivity and real-time updates.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: Offers dynamic views such as Kanban, Gantt Chart, and Mind Map for comprehensive visualization of tasks and dependencies, facilitating better risk assessment and management by providing a clear picture of the project\u2019s status.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Mapped Dependencies vs. Implicit Task Relationships:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Dependencies between tasks are often unverifiable or documented separately, leading to oversight.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: Clearly maps out task relations with parent-child cards, ensuring all dependencies are visible and managed, reducing risks of premature project execution.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Proactive Notifications vs. Manual Status Checks:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Relies on manual updates and status checks, which are inefficient and prone to delays.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: Provides notifications that alert team members to changes and potential issues in real-time, allowing for immediate response and adjustment to mitigate risks.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Visible Blockers vs. Unidentified Obstacles:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Blockers remain undocumented or are manually logged without a standardized process, leading to unresolved issues.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: Encourages the use of visible blockers, categorized as local, global, or on-demand, allowing for immediate identification and prioritization, which enhances risk management and resolution efficiency.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Document Management Integration vs. Isolated File Systems:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old School: Uses isolated file systems where accessing the right documents can be time-consuming.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo: Incorporates integrated document management, allowing for easy linking and access to essential files across tasks, improving traceability and reducing the risk of compliance issues.<\/p><p class=\"tekst-para wp-block-paragraph\">In conclusion, KanBo transforms risk visibility and management for pharmaceutical data scientists by integrating all project elements into a cohesive, easy-to-navigate system that supports real-time collaboration and dynamic management of risks, replacing outdated tools with a robust framework tailored to meet the complex demands of pharmaceutical data projects.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section5\">What will not change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the realm of Risk Visibility for Senior Data Scientists in Pharma, certain aspects remain unchanged despite advancements in technology. Leadership judgment, strategy ownership, and accountability continue to rely heavily on human insight and decision-making. Technology serves as an amplifier, offering tools that enhance these human-driven processes. A human-first approach ensures that while data and analytics tools provide support, the ultimate responsibility and ethical considerations rest with individuals who interpret data within the context of health outcomes and patient safety. These constants ensure that, no matter the technological evolution, the human element remains at the core of critical risk management and decision-making processes.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section6\">Key management questions (Q\/A)<\/h3><p class=\"tekst-para wp-block-paragraph\">- Who did what and when?  <\/p><p class=\"tekst-para wp-block-paragraph\">Tracking software like KanBo can log actions, allowing senior data scientists to see who executed specific tasks and when, thus maintaining accountability and streamline project management.<\/p><p class=\"tekst-para wp-block-paragraph\">- What threatens the critical path?  <\/p><p class=\"tekst-para wp-block-paragraph\">Factors such as data inaccuracies, model failures, or regulatory compliance issues can threaten the critical path. Visibility into these areas helps identify and address potential risks ahead of time.<\/p><p class=\"tekst-para wp-block-paragraph\">- Where are bottlenecks?  <\/p><p class=\"tekst-para wp-block-paragraph\">Bottlenecks may occur at stages involving data access, computational resource limitations, or during the approval process. Mapping card dependencies can help identify these areas, enabling proactive measures to alleviate them.<\/p><p class=\"tekst-para wp-block-paragraph\">- Which tasks are overdue and why?  <\/p><p class=\"tekst-para wp-block-paragraph\">Tasks may be overdue due to issues like insufficient computational resources, data barriers, or overlapping timelines (date conflicts). Visibility into task progress and blockers can help determine the specific causes of delays.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section7\">Atomic Facts<\/h3><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Fines and Recalls: The pharmaceutical industry is heavily regulated, with non-compliance resulting in significant financial penalties. A single recall can cost a company over $100 million, emphasizing the need for robust risk visibility mechanisms to ensure adherence to regulations (source: industry reports).<\/p><p class=\"tekst-para wp-block-paragraph\">2. R&D Risk Visibility: Developing a new drug typically spans 10\u201315 years and costs billions. Clear visibility into potential R&D risks can streamline decision-making, potentially saving significant resources by addressing issues early in the process (source: PhRMA).<\/p><p class=\"tekst-para wp-block-paragraph\">3. Supply Chain Disruptions: The complexity of global pharmaceutical supply chains necessitates proactive risk management. Visibility into potential risks such as geopolitical tensions or transport delays can prevent major operational disruptions (source: pharmaceutical logistics studies).<\/p><p class=\"tekst-para wp-block-paragraph\">4. Financial Impact of Delays: Companies may lose billions in potential revenue due to delayed drug approvals, highlighting the critical financial implications of risk inaction (source: Deloitte analysis on pharmaceutical sales impact).<\/p><p class=\"tekst-para wp-block-paragraph\">5. Data-Driven Risk Management: Implementing data analytics for risk visibility allows pharmaceutical companies to align risk management strategies with corporate goals, enhancing both compliance and operational efficiency (source: corporate risk management case studies).<\/p><p class=\"tekst-para wp-block-paragraph\">6. Technology as an Enabler: Tools like KanBo can aid in visualizing risks through mapped dependencies and visible blockers, ensuring that critical issues are addressed promptly, reducing potential financial and operational impacts (source: software solution reviews).<\/p><p class=\"tekst-para wp-block-paragraph\">7. Project Timeline Integrity: Risk visibility tools help manage potential project timeline conflicts, ensuring that overlapping deadlines or tasks are adjusted to minimize disruption in drug development and approval processes (source: project management literature).<\/p><p class=\"tekst-para wp-block-paragraph\">8. Reputational Protection: Effective risk management, supported by advanced visibility tools, can protect a company\u2019s reputation by ensuring that adverse incidents are quickly identified and mitigated, maintaining public trust and market value (source: industry reputation studies).<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section8\">Mini-FAQ<\/h3><p class=\"tekst-para wp-block-paragraph\">1. What does risk visibility mean for a Senior Data Scientist in the pharmaceutical industry?<\/p><p class=\"tekst-para wp-block-paragraph\">   Risk visibility refers to the ability to identify, assess, and manage potential risks that could impact projects or tasks. This can include risks associated with data inaccuracies, model failures, regulatory compliance issues, and project timelines.<\/p><p class=\"tekst-para wp-block-paragraph\">2. How can pharmaceutical companies ensure regulatory compliance through risk visibility?<\/p><p class=\"tekst-para wp-block-paragraph\">   By maintaining clear visibility over risk-related processes, pharmaceutical companies can ensure adherence to regulations from agencies like the FDA and EMA. This includes systematically managing and monitoring risks to avoid substantial fines, product recalls, or the suspension of operations.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Why is risk visibility crucial for product safety in the pharmaceutical industry?<\/p><p class=\"tekst-para wp-block-paragraph\">   Ensuring drug safety is imperative, and risk visibility helps in identifying potential risks that could lead to adverse effects. It prevents unnoticed issues that could harm patients and result in legal and reputational repercussions.<\/p><p class=\"tekst-para wp-block-paragraph\">4. What role does risk visibility play in Research & Development (R&D) in pharmaceuticals?<\/p><p class=\"tekst-para wp-block-paragraph\">   With the high cost and extended timelines of drug development, visibility into R&D risks helps make informed decisions and mitigate losses from unsuccessful trials or unforeseen side effects.<\/p><p class=\"tekst-para wp-block-paragraph\">5. How does risk visibility affect the pharmaceutical supply chain?<\/p><p class=\"tekst-para wp-block-paragraph\">   Risk visibility helps manage complexities such as delivery delays, contamination, and geopolitical disruptions. It allows for better contingency planning and resource allocation across the extensive and global supply chains.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Can risk visibility enhance competitiveness in the pharmaceutical market?<\/p><p class=\"tekst-para wp-block-paragraph\">   Yes, risk visibility can enhance decision-making by prioritizing initiatives with the highest potential return on investment and the lowest risk, which is vital in the highly competitive pharmaceutical market.<\/p><p class=\"tekst-para wp-block-paragraph\">7. How can tools like KanBo improve risk visibility for data scientists in pharmaceuticals?<\/p><p class=\"tekst-para wp-block-paragraph\">   KanBo provides a holistic view through visible blockers, mapped dependencies, and proactive notifications. This framework helps data scientists manage and mitigate risks by ensuring they are informed and tasks proceed in an orderly manner.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section9\">Data Table<\/h3><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+------------------------------------------------------------+-------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Key Pressure      | Description                                                | Examples                                               |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+------------------------------------------------------------+-------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Regulatory        | Compliance with agencies like FDA, EMA.                    | Non-compliance fines, product recalls.                 |<\/p><p class=\"tekst-para wp-block-paragraph\">| Compliance        | Visibility ensures adherence to regulations.               |                                                        |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+------------------------------------------------------------+-------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Product Safety    | Systematic risk management to ensure drug safety.          | Unseen adverse effects, legal repercussions, reputational damage. |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+------------------------------------------------------------+-------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| R&D Costs         | High costs and time in drug development.                   | Unsuccessful trials, unforeseen side effects.          |<\/p><p class=\"tekst-para wp-block-paragraph\">|                   | Visibility aids informed decision-making.                  |                                                        |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+------------------------------------------------------------+-------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Supply Chain      | Complex, global supply chains.                             | Delivery delays, contamination, geopolitical disruptions. |<\/p><p class=\"tekst-para wp-block-paragraph\">| Complexity        | Visibility enables better planning and resource allocation.|                                                        |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+------------------------------------------------------------+-------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Market Pressures  | Competitive market with a constant push for innovation.    | Risk visibility aids in prioritizing high-ROI initiatives. |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+------------------------------------------------------------+-------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">                                                                                       <\/p><p class=\"tekst-para wp-block-paragraph\">+--------------------------+-----------------------------------+-----------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Quantifying the Risk of  | Financial Losses                  | Non-compliance fines, recall costs, lost revenue.        |<\/p><p class=\"tekst-para wp-block-paragraph\">| Inaction                 |                                   |                                                       |<\/p><p class=\"tekst-para wp-block-paragraph\">+--------------------------+-----------------------------------+-----------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">|                          | Product Delays                    | Delayed drug approval, loss of market share.          |<\/p><p class=\"tekst-para wp-block-paragraph\">+--------------------------+-----------------------------------+-----------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">|                          | Reputational Damage               | Erosion of public trust, market value decline.        |<\/p><p class=\"tekst-para wp-block-paragraph\">+--------------------------+-----------------------------------+-----------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">|                          | Operational Disruptions           | Supply chain interruptions, production halts.         |<\/p><p class=\"tekst-para wp-block-paragraph\">+--------------------------+-----------------------------------+-----------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+---------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| KanBo Features    | How It Enhances Risk Visibility                                           |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+---------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Visible Blockers  | Categorizes and displays issues (local, global, on-demand) for prioritization. |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+---------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Mapped            | Shows task dependencies, clarifying project workflow and order of execution. |<\/p><p class=\"tekst-para wp-block-paragraph\">| Dependencies      |                                                                           |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+---------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Notifications     | Keeps stakeholders informed with updates, helping manage potential risks.   |<\/p><p class=\"tekst-para wp-block-paragraph\">+-------------------+---------------------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">This table summarizes the key pressures faced by pharmaceutical companies in terms of risk visibility, quantifies the risk of inaction, and outlines how KanBo features can aid in managing these risks effectively for a Senior Data Scientist in the pharmaceutical industry.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section10\">Answer Capsule<\/h3><p class=\"tekst-para wp-block-paragraph\">To solve risk visibility for a Senior Data Scientist in the pharmaceutical sector, follow these steps:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Data Quality and Integrity: Ensure the data used in analyses is clean, accurate, and complete. Implement ETL processes (Extract, Transform, Load) with automated data validation checks to mitigate risks of using flawed data which could lead to incorrect models and analyses.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Risk Identification: Use advanced analytics to identify potential risks in data analytics projects. This includes risks related to data breaches, algorithmic biases, and model inaccuracies.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Regulatory Compliance: Stay informed about regulations (via continuous education or specialized software) that impact data use and ensure all modeling and data processing comply with these. Regular audits can help ensure adherence and identify non-compliance risks early.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Model Monitoring: Once models are deployed, establish a robust monitoring system for performance and drift. Use Key Performance Indicators (KPIs) to alert you to discrepancies suggesting model performance issues or data drift that could impact insights.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Collaboration Tools: Leverage project management and collaboration tools like KanBo to map dependencies, manage tasks, and give visibility into potential blockers in data projects. This reduces project overruns and ensures alignment among stakeholders.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Proactive Risk Management: Establish a framework for capturing and analyzing incidents using predictive analytics to anticipate potential project delays, data issues, or compliance challenges before they escalate.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Stakeholder Communication: Implement a communication protocol involving regular updates and risk reports to all relevant stakeholders. This includes establishing channels for instant alerts for any risk-related updates or changes.<\/p><p class=\"tekst-para wp-block-paragraph\">By addressing these key areas with a structured, proactive approach, a Senior Data Scientist can effectively manage risk visibility and enhance decision-making quality in pharmaceutical analytics projects.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section11\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/h3><p class=\"tekst-para-maly wp-block-paragraph\">```json<\/p><p class=\"tekst-para-maly wp-block-paragraph\">(<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"PharmaceuticalIndustryRiskVisibility\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"KeyPressures\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"RegulatoryCompliance\": \"Maintaining risk visibility ensures adherence to regulations, avoiding fines and operational suspensions.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"ProductSafety\": \"Systematic risk management prevents unnoticed adverse effects and legal\/reputational issues.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"R&D Costs\": \"Visibility into risks of unsuccessful trials helps mitigate financial losses.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"SupplyChainComplexity\": \"Monitoring risks such as delays or disruptions enhances contingency planning.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"MarketPressures\": \"Visibility aids in prioritizing low-risk, high-return initiatives.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"RiskOfInaction\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"FinancialLosses\": \"Non-compliance and product recalls can lead to loss of millions.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"ProductDelays\": \"Time-to-market delays result in lost revenue and market share.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"ReputationalDamage\": \"Public trust erosion due to incidents takes years to rebuild.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"OperationalDisruptions\": \"Supply chain interruptions cause costly downtimes.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"KanBoRiskManagementFramework\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"VisibleBlockers\": \"Categorizes and prioritizes resource allocation based on blocker type.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"MappedDependencies\": \"Streamlines workflows by clarifying task dependencies.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Notifications\": \"Informs stakeholders of status changes, assisting in rapid risk mitigation.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"Definitions\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"RiskVisibility\": \"Identifying and managing potential project risks.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"CardBlockers\": \"Obstacles halting task progress, categorized for attention.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"DateConflict\": \"Overlapping timelines causing scheduling issues.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"CardRelation\": \"Task dependencies affecting workflow sequence.\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Notification\": \"Alerts keeping team members informed of task developments.\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">)<\/p><p class=\"tekst-para-maly wp-block-paragraph\">```<\/p><h3 class=\"wp-block-heading naglowek-start compact-nag\">Additional Resources<\/h3><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-f81cac751942179cffc5595ea3093d69 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-80007a93c5109043d5274205e4d68368 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-23fbce8bb46a861d3991ae1a29f1d971 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:0px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wp-block-column pasek-prawy spis2 jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-right:16px;padding-left:16px\"><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-40115c86dc2fe150fd9b1ed5dc10196e wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-02abac7c05b8b530fd3b1b7827aca587 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-09306734556c91c46ae8064a30b664b3 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3013,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-71273","page","type-page","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Transforming Pharmaceutical Risk Management: Enhancing Visibility to Navigate Regulatory Safety and Market Challenges for Senior Data Scientists - KanBo<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Transforming Pharmaceutical Risk Management: Enhancing Visibility to Navigate Regulatory Safety and Market Challenges for Senior Data Scientists - KanBo\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/\" \/>\r\n<meta property=\"og:site_name\" content=\"KanBo\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"17 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\\\/\",\"name\":\"Transforming Pharmaceutical Risk Management: Enhancing Visibility to Navigate Regulatory Safety and Market Challenges for Senior Data Scientists - KanBo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\"},\"datePublished\":\"2025-09-18T09:59:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industries\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"KanBo for Pharmaceutical\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Transforming Pharmaceutical Risk Management: Enhancing Visibility to Navigate Regulatory Safety and Market Challenges for Senior Data Scientists\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"name\":\"KanBo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\",\"name\":\"KanBo\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"contentUrl\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"width\":196,\"height\":52,\"caption\":\"KanBo\"},\"image\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transforming Pharmaceutical Risk Management: Enhancing Visibility to Navigate Regulatory Safety and Market Challenges for Senior Data Scientists - KanBo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/","og_locale":"en_US","og_type":"article","og_title":"Transforming Pharmaceutical Risk Management: Enhancing Visibility to Navigate Regulatory Safety and Market Challenges for Senior Data Scientists - KanBo","og_url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/","og_site_name":"KanBo","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"17 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/","url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/","name":"Transforming Pharmaceutical Risk Management: Enhancing Visibility to Navigate Regulatory Safety and Market Challenges for Senior Data Scientists - KanBo","isPartOf":{"@id":"https:\/\/kanboapp.com\/en\/#website"},"datePublished":"2025-09-18T09:59:36+00:00","breadcrumb":{"@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/transforming-pharmaceutical-risk-management-enhancing-visibility-to-navigate-regulatory-safety-and-market-challenges-for-senior-data-scientists\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kanboapp.com\/en\/"},{"@type":"ListItem","position":2,"name":"Industries","item":"https:\/\/kanboapp.com\/en\/industries\/"},{"@type":"ListItem","position":3,"name":"KanBo for Pharmaceutical","item":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/"},{"@type":"ListItem","position":4,"name":"Transforming Pharmaceutical Risk Management: Enhancing Visibility to Navigate Regulatory Safety and Market Challenges for Senior Data Scientists"}]},{"@type":"WebSite","@id":"https:\/\/kanboapp.com\/en\/#website","url":"https:\/\/kanboapp.com\/en\/","name":"KanBo","description":"","publisher":{"@id":"https:\/\/kanboapp.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kanboapp.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kanboapp.com\/en\/#organization","name":"KanBo","url":"https:\/\/kanboapp.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","contentUrl":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","width":196,"height":52,"caption":"KanBo"},"image":{"@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71273","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/comments?post=71273"}],"version-history":[{"count":0,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71273\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/3013"}],"wp:attachment":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/media?parent=71273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}